Immunodiagnostic Systems Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Immunodiagnostic Systems Holdings's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1% to $38,513,000. Profit margin reached 2%. Total operating expenses were $16,356,000.
Profit Margin
| 2010 | 37.15M | 8.07M | 21.73% |
|---|---|---|---|
| 2011 | 50.16M | 12.99M | 25.9% |
| 2012 | 53.67M | 4.73M | 8.83% |
| 2015 | 45.36M | 2.35M | 5.18% |
| 2016 | 38.30M | -32.17M | -83.98% |
| 2018 | 37.94M | 1.22M | 3.23% |
| 2019 | 38.51M | 796K | 2.07% |
IDH.L Income Statement (2010 – 2018)
| 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 38.51M | 37.94M | 38.30M | 45.36M | 53.67M | 50.16M | 37.15M |
Cost of revenue | 21.81M | 19.93M | 15.84M | 17.03M | 13.57M | 12.71M | 9.64M |
Gross profit | 16.69M | 18.01M | 22.46M | 28.33M | 40.09M | 37.45M | 27.51M |
Operating exp. | |||||||
Research and development | 2.44M | 1.67M | 1.03M | 1.62M | 1.89M | 725K | 122K |
Selling and marketing | 9.07M | 9.37M | 9.10M | 9.92M | 8.4M | 7.05M | 5.92M |
Total operating expenses | 16.35M | 16.55M | 20.67M | 23.39M | 30.19M | 20.21M | 16.45M |
Operating income | 340K | 1.46M | 1.78M | 4.93M | 9.89M | 17.23M | 11.06M |
Other income (expenses), net | 502K | -527K | -38.81M | -883K | -2.64M | 602K | 80K |
Income before tax | 842K | 935K | -37.02M | 4.05M | 7.25M | 16.63M | 10.98M |
Income tax expense | 46K | -292K | -4.85M | 1.70M | 2.51M | 3.64M | 2.91M |
Net income | 796K | 1.22M | -32.17M | 2.35M | 4.73M | 12.99M | 8.07M |
Earnings per share | |||||||
Basic EPS | 0.02 | 0.04 | -1.1 | 0.08 | 0.16 | 0.46 | 0.30 |
Diluted EPS | 0.02 | 0.04 | -1.1 | 0.07 | 0.16 | 0.44 | 0.28 |
| Data source | Data source | Data source |